Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain

Little is known on the characteristics of patients diagnosed with idiopathic pulmonary fibrosis (IPF) in Spain. We aimed to characterize the demographic and clinical profile of IPF patients included in the IPF National Registry of the Spanish Respiratory Society (SEPAR). This is a prospective, obser...

Descripción completa

Detalles Bibliográficos
Autores: Fernández-Fabrellas, Estrella, Molina Molina, Maria|||0000-0002-1852-1723, Soriano, Joan B.|||0000-0001-9740-2994, Rodríguez Portal, José Antonio, Ancochea, Julio|||0000-0001-7451-4133, Valenzuela, Claudia|||0000-0002-0856-6290, Xaubet, Antoni, Aburto, Myriam|||0000-0001-8644-1015, Alfageme, Inmaculada|||0000-0002-5106-1669, Bollo de Miguel, Elena, Cano, Esteban, Casanova Espinosa, Álvaro, Castillo, Diego|||0000-0002-4862-3595, Figuerola Mendal, J.A., García Sevila, Raquel|||0000-0002-4218-793X, Gaudó Navarro, Javier I., Gómez-Carrera, Luis, Saez González, Jesus Miguel, Herrera Lara, Susana, Laporta Hernández, Rosalía, Marín González, M., Nieto Barbero, Asunción, Portillo, Karina|||0000-0002-7804-1051, Romero, Ana Dolores, Sánchez Simón-Talero, Rafaela, Sancho Chust, José N.|||0000-0002-3028-0715, Sellares, Jacobo, Soler-Sempere, Maria J.|||0000-0002-6607-2037, Sauleda, Jaume|||0000-0002-9806-3370, Tomás López, Laura, Villanueva, Manuel Angel|||0000-0003-3256-9579
Tipo de recurso: artículo
Fecha de publicación:2019
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:285821
Acceso en línea:https://ddd.uab.cat/record/285821
https://dx.doi.org/urn:doi:10.1186/s12931-019-1084-0
Access Level:acceso abierto
Palabra clave:Anti-fibrotic treatment
Idiopathic pulmonary fibrosis
National registry
SEPAR
Spain
id ES_770e907e1d4abc7e57ec4cc55b2d6313
oai_identifier_str oai:ddd.uab.cat:285821
network_acronym_str ES
network_name_str España
repository_id_str
spelling Demographic and clinical profile of idiopathic pulmonary fibrosis patients in SpainThe SEPAR National RegistryFernández-Fabrellas, EstrellaMolina Molina, Maria|||0000-0002-1852-1723Soriano, Joan B.|||0000-0001-9740-2994Rodríguez Portal, José AntonioAncochea, Julio|||0000-0001-7451-4133Valenzuela, Claudia|||0000-0002-0856-6290Xaubet, AntoniAburto, Myriam|||0000-0001-8644-1015Alfageme, Inmaculada|||0000-0002-5106-1669Bollo de Miguel, ElenaCano, EstebanCasanova Espinosa, ÁlvaroCastillo, Diego|||0000-0002-4862-3595Figuerola Mendal, J.A.García Sevila, Raquel|||0000-0002-4218-793XGaudó Navarro, Javier I.Gómez-Carrera, LuisSaez González, Jesus MiguelHerrera Lara, SusanaLaporta Hernández, RosalíaMarín González, M.Nieto Barbero, AsunciónPortillo, Karina|||0000-0002-7804-1051Romero, Ana DoloresSánchez Simón-Talero, RafaelaSancho Chust, José N.|||0000-0002-3028-0715Sellares, JacoboSoler-Sempere, Maria J.|||0000-0002-6607-2037Sauleda, Jaume|||0000-0002-9806-3370Tomás López, LauraVillanueva, Manuel Angel|||0000-0003-3256-9579Anti-fibrotic treatmentIdiopathic pulmonary fibrosisNational registrySEPARSpainLittle is known on the characteristics of patients diagnosed with idiopathic pulmonary fibrosis (IPF) in Spain. We aimed to characterize the demographic and clinical profile of IPF patients included in the IPF National Registry of the Spanish Respiratory Society (SEPAR). This is a prospective, observational, multicentre and nationwide study that involved 608 IPF patients included in the SEPAR IPF Registry up to June 27th, 2017, and who received any treatment for their disease. IPF patients were predominantly males, ex-smokers, and aged in their 70s, similar to other registries. Upon inclusion, mean ± SD predicted forced vital capacity was 77.6% ± 19.4, diffusing capacity for carbon monoxide was 48.5% ± 17.7, and the 6-min walk distance was 423.5 m ± 110.4. The diagnosis was mainly established on results from the high-resolution computed tomography in the proper clinical context (55.0% of patients), while 21.2% of patients required invasive procedures (surgical lung biopsy) for definitive diagnosis. Anti-fibrotic treatment was prescribed in 69.4% of cases, 51.5% pirfenidone and 17.9% nintedanib, overall with a good safety profile. The SEPAR IPF Registry should help to further characterize current characteristics and future trends of IPF patients in Spain and compare/pool them with other registries and cohorts.Universitat Autònoma de Barcelona 22019-01-0120192019-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/285821https://dx.doi.org/urn:doi:10.1186/s12931-019-1084-0reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2858212026-06-06T12:50:31Z
dc.title.none.fl_str_mv Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain
The SEPAR National Registry
title Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain
spellingShingle Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain
Fernández-Fabrellas, Estrella
Anti-fibrotic treatment
Idiopathic pulmonary fibrosis
National registry
SEPAR
Spain
title_short Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain
title_full Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain
title_fullStr Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain
title_full_unstemmed Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain
title_sort Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain
dc.creator.none.fl_str_mv Fernández-Fabrellas, Estrella
Molina Molina, Maria|||0000-0002-1852-1723
Soriano, Joan B.|||0000-0001-9740-2994
Rodríguez Portal, José Antonio
Ancochea, Julio|||0000-0001-7451-4133
Valenzuela, Claudia|||0000-0002-0856-6290
Xaubet, Antoni
Aburto, Myriam|||0000-0001-8644-1015
Alfageme, Inmaculada|||0000-0002-5106-1669
Bollo de Miguel, Elena
Cano, Esteban
Casanova Espinosa, Álvaro
Castillo, Diego|||0000-0002-4862-3595
Figuerola Mendal, J.A.
García Sevila, Raquel|||0000-0002-4218-793X
Gaudó Navarro, Javier I.
Gómez-Carrera, Luis
Saez González, Jesus Miguel
Herrera Lara, Susana
Laporta Hernández, Rosalía
Marín González, M.
Nieto Barbero, Asunción
Portillo, Karina|||0000-0002-7804-1051
Romero, Ana Dolores
Sánchez Simón-Talero, Rafaela
Sancho Chust, José N.|||0000-0002-3028-0715
Sellares, Jacobo
Soler-Sempere, Maria J.|||0000-0002-6607-2037
Sauleda, Jaume|||0000-0002-9806-3370
Tomás López, Laura
Villanueva, Manuel Angel|||0000-0003-3256-9579
author Fernández-Fabrellas, Estrella
author_facet Fernández-Fabrellas, Estrella
Molina Molina, Maria|||0000-0002-1852-1723
Soriano, Joan B.|||0000-0001-9740-2994
Rodríguez Portal, José Antonio
Ancochea, Julio|||0000-0001-7451-4133
Valenzuela, Claudia|||0000-0002-0856-6290
Xaubet, Antoni
Aburto, Myriam|||0000-0001-8644-1015
Alfageme, Inmaculada|||0000-0002-5106-1669
Bollo de Miguel, Elena
Cano, Esteban
Casanova Espinosa, Álvaro
Castillo, Diego|||0000-0002-4862-3595
Figuerola Mendal, J.A.
García Sevila, Raquel|||0000-0002-4218-793X
Gaudó Navarro, Javier I.
Gómez-Carrera, Luis
Saez González, Jesus Miguel
Herrera Lara, Susana
Laporta Hernández, Rosalía
Marín González, M.
Nieto Barbero, Asunción
Portillo, Karina|||0000-0002-7804-1051
Romero, Ana Dolores
Sánchez Simón-Talero, Rafaela
Sancho Chust, José N.|||0000-0002-3028-0715
Sellares, Jacobo
Soler-Sempere, Maria J.|||0000-0002-6607-2037
Sauleda, Jaume|||0000-0002-9806-3370
Tomás López, Laura
Villanueva, Manuel Angel|||0000-0003-3256-9579
author_role author
author2 Molina Molina, Maria|||0000-0002-1852-1723
Soriano, Joan B.|||0000-0001-9740-2994
Rodríguez Portal, José Antonio
Ancochea, Julio|||0000-0001-7451-4133
Valenzuela, Claudia|||0000-0002-0856-6290
Xaubet, Antoni
Aburto, Myriam|||0000-0001-8644-1015
Alfageme, Inmaculada|||0000-0002-5106-1669
Bollo de Miguel, Elena
Cano, Esteban
Casanova Espinosa, Álvaro
Castillo, Diego|||0000-0002-4862-3595
Figuerola Mendal, J.A.
García Sevila, Raquel|||0000-0002-4218-793X
Gaudó Navarro, Javier I.
Gómez-Carrera, Luis
Saez González, Jesus Miguel
Herrera Lara, Susana
Laporta Hernández, Rosalía
Marín González, M.
Nieto Barbero, Asunción
Portillo, Karina|||0000-0002-7804-1051
Romero, Ana Dolores
Sánchez Simón-Talero, Rafaela
Sancho Chust, José N.|||0000-0002-3028-0715
Sellares, Jacobo
Soler-Sempere, Maria J.|||0000-0002-6607-2037
Sauleda, Jaume|||0000-0002-9806-3370
Tomás López, Laura
Villanueva, Manuel Angel|||0000-0003-3256-9579
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universitat Autònoma de Barcelona
dc.subject.none.fl_str_mv Anti-fibrotic treatment
Idiopathic pulmonary fibrosis
National registry
SEPAR
Spain
topic Anti-fibrotic treatment
Idiopathic pulmonary fibrosis
National registry
SEPAR
Spain
description Little is known on the characteristics of patients diagnosed with idiopathic pulmonary fibrosis (IPF) in Spain. We aimed to characterize the demographic and clinical profile of IPF patients included in the IPF National Registry of the Spanish Respiratory Society (SEPAR). This is a prospective, observational, multicentre and nationwide study that involved 608 IPF patients included in the SEPAR IPF Registry up to June 27th, 2017, and who received any treatment for their disease. IPF patients were predominantly males, ex-smokers, and aged in their 70s, similar to other registries. Upon inclusion, mean ± SD predicted forced vital capacity was 77.6% ± 19.4, diffusing capacity for carbon monoxide was 48.5% ± 17.7, and the 6-min walk distance was 423.5 m ± 110.4. The diagnosis was mainly established on results from the high-resolution computed tomography in the proper clinical context (55.0% of patients), while 21.2% of patients required invasive procedures (surgical lung biopsy) for definitive diagnosis. Anti-fibrotic treatment was prescribed in 69.4% of cases, 51.5% pirfenidone and 17.9% nintedanib, overall with a good safety profile. The SEPAR IPF Registry should help to further characterize current characteristics and future trends of IPF patients in Spain and compare/pool them with other registries and cohorts.
publishDate 2019
dc.date.none.fl_str_mv 2
2019-01-01
2019
2019-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/285821
https://dx.doi.org/urn:doi:10.1186/s12931-019-1084-0
url https://ddd.uab.cat/record/285821
https://dx.doi.org/urn:doi:10.1186/s12931-019-1084-0
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869411095486136320
score 15.300724